The Response of RIF-1 Fibrosarcomas to the Vascular-Disrupting Agent ZD6126 Assessed by In Vivo and Ex Vivo1H Magnetic Resonance Spectroscopy
Open Access
- 1 July 2006
- journal article
- Published by Elsevier BV in Neoplasia
- Vol. 8 (7), 560-567
- https://doi.org/10.1593/neo.06319
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Effects of the Vascular Disrupting Agent ZD6126 on Interstitial Fluid Pressure and Cell Survival in TumorsCancer Research, 2006
- Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of the Choline Kinase Inhibitor MN58b in Human Carcinoma ModelsCancer Research, 2006
- The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRSActa Oncologica, 2006
- Metabolite changes in HT-29 xenograft tumors following HIF-1α inhibition with PX-478 as studied by MR spectroscopyin vivo andex vivoNMR in Biomedicine, 2005
- Tumor Dose Response to the Vascular Disrupting Agent, 5,6-Dimethylxanthenone-4-Acetic Acid, Using In vivo Magnetic Resonance SpectroscopyClinical Cancer Research, 2005
- High‐resolution magic‐angle‐spinning 1H NMR spectroscopy reveals different responses in choline‐containing metabolites upon gene therapy‐induced programmed cell death in rat brain gliomaNMR in Biomedicine, 2005
- Comparisons of brain metabolites observed by HRMAS 1H NMR of intact tissue and solution 1H NMR of tissue extracts in SIV‐infected macaquesNMR in Biomedicine, 2005
- Positron emission tomographic imaging of angiogenesis and vascular functionThe British Journal of Radiology, 2003
- 1H MR spectroscopy of brain tumours and massesNMR in Biomedicine, 2003
- Accurate quantification of in vivo31P NMR signals using the variable projection method and prior knowledgeMagnetic Resonance in Medicine, 1988